In Vivo Amphetamine Action is Contingent on αCaMKII

Addiction to psychostimulants (ie, amphetamines and cocaine) imposes a major socioeconomic burden. Prevention and treatment represent unmet medical needs, which may be addressed, if the mechanisms underlying psychostimulant action are understood. Cocaine acts as a blocker at the transporters for dop...

Full description

Bibliographic Details
Main Authors: Steinkellner, Thomas, Mus, Liudmilla, Eisenrauch, Birgit, Constantinescu, Andreea, Leo, Damiana, Konrad, Lisa, Rickhag, Mattias, Sørensen, Gunnar, Efimova, Evgenia V, Kong, Eryan, Willeit, Matthäus, Sotnikova, Tatyana D, Kudlacek, Oliver, Gether, Ulrik, Freissmuth, Michael, Pollak, Daniela D, Gainetdinov, Raul R, Sitte, Harald H
Format: Online
Language:English
Published: Nature Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207348/
id pubmed-4207348
recordtype oai_dc
spelling pubmed-42073482014-10-27 In Vivo Amphetamine Action is Contingent on αCaMKII Steinkellner, Thomas Mus, Liudmilla Eisenrauch, Birgit Constantinescu, Andreea Leo, Damiana Konrad, Lisa Rickhag, Mattias Sørensen, Gunnar Efimova, Evgenia V Kong, Eryan Willeit, Matthäus Sotnikova, Tatyana D Kudlacek, Oliver Gether, Ulrik Freissmuth, Michael Pollak, Daniela D Gainetdinov, Raul R Sitte, Harald H Original Article Addiction to psychostimulants (ie, amphetamines and cocaine) imposes a major socioeconomic burden. Prevention and treatment represent unmet medical needs, which may be addressed, if the mechanisms underlying psychostimulant action are understood. Cocaine acts as a blocker at the transporters for dopamine (DAT), serotonin (SERT), and norepinephrine (NET), but amphetamines are substrates that do not only block the uptake of monoamines but also induce substrate efflux by promoting reverse transport. Reverse transport has been a focus of research for decades but its mechanistic basis still remains enigmatic. Recently, transporter-interacting proteins were found to regulate amphetamine-triggered reverse transport: calmodulin kinase IIα (αCaMKII) is a prominent example, because it binds the carboxyl terminus of DAT, phosphorylates its amino terminus, and supports amphetamine-induced substrate efflux in vitro. Here, we investigated whether, in vivo, the action of amphetamine was contingent on the presence of αCaMKII by recording the behavioral and neurochemical effects of amphetamine. Measurement of dopamine efflux in the dorsal striatum by microdialysis revealed that amphetamine induced less dopamine efflux in mice lacking αCaMKII. Consistent with this observation, the acute locomotor responses to amphetamine were also significantly blunted in αCaMKII-deficient mice. In addition, while the rewarding properties of amphetamine were preserved in αCaMKII-deficient mice, their behavioral sensitization to amphetamine was markedly reduced. Our findings demonstrate that amphetamine requires the presence of αCaMKII to elicit a full-fledged effect on DAT in vivo: αCaMKII does not only support acute amphetamine-induced dopamine efflux but is also important in shaping the chronic response to amphetamine. Nature Publishing Group 2014-10 2014-06-25 /pmc/articles/PMC4207348/ /pubmed/24871545 http://dx.doi.org/10.1038/npp.2014.124 Text en Copyright © 2014 American College of Neuropsychopharmacology http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Steinkellner, Thomas
Mus, Liudmilla
Eisenrauch, Birgit
Constantinescu, Andreea
Leo, Damiana
Konrad, Lisa
Rickhag, Mattias
Sørensen, Gunnar
Efimova, Evgenia V
Kong, Eryan
Willeit, Matthäus
Sotnikova, Tatyana D
Kudlacek, Oliver
Gether, Ulrik
Freissmuth, Michael
Pollak, Daniela D
Gainetdinov, Raul R
Sitte, Harald H
spellingShingle Steinkellner, Thomas
Mus, Liudmilla
Eisenrauch, Birgit
Constantinescu, Andreea
Leo, Damiana
Konrad, Lisa
Rickhag, Mattias
Sørensen, Gunnar
Efimova, Evgenia V
Kong, Eryan
Willeit, Matthäus
Sotnikova, Tatyana D
Kudlacek, Oliver
Gether, Ulrik
Freissmuth, Michael
Pollak, Daniela D
Gainetdinov, Raul R
Sitte, Harald H
In Vivo Amphetamine Action is Contingent on αCaMKII
author_facet Steinkellner, Thomas
Mus, Liudmilla
Eisenrauch, Birgit
Constantinescu, Andreea
Leo, Damiana
Konrad, Lisa
Rickhag, Mattias
Sørensen, Gunnar
Efimova, Evgenia V
Kong, Eryan
Willeit, Matthäus
Sotnikova, Tatyana D
Kudlacek, Oliver
Gether, Ulrik
Freissmuth, Michael
Pollak, Daniela D
Gainetdinov, Raul R
Sitte, Harald H
author_sort Steinkellner, Thomas
title In Vivo Amphetamine Action is Contingent on αCaMKII
title_short In Vivo Amphetamine Action is Contingent on αCaMKII
title_full In Vivo Amphetamine Action is Contingent on αCaMKII
title_fullStr In Vivo Amphetamine Action is Contingent on αCaMKII
title_full_unstemmed In Vivo Amphetamine Action is Contingent on αCaMKII
title_sort in vivo amphetamine action is contingent on αcamkii
description Addiction to psychostimulants (ie, amphetamines and cocaine) imposes a major socioeconomic burden. Prevention and treatment represent unmet medical needs, which may be addressed, if the mechanisms underlying psychostimulant action are understood. Cocaine acts as a blocker at the transporters for dopamine (DAT), serotonin (SERT), and norepinephrine (NET), but amphetamines are substrates that do not only block the uptake of monoamines but also induce substrate efflux by promoting reverse transport. Reverse transport has been a focus of research for decades but its mechanistic basis still remains enigmatic. Recently, transporter-interacting proteins were found to regulate amphetamine-triggered reverse transport: calmodulin kinase IIα (αCaMKII) is a prominent example, because it binds the carboxyl terminus of DAT, phosphorylates its amino terminus, and supports amphetamine-induced substrate efflux in vitro. Here, we investigated whether, in vivo, the action of amphetamine was contingent on the presence of αCaMKII by recording the behavioral and neurochemical effects of amphetamine. Measurement of dopamine efflux in the dorsal striatum by microdialysis revealed that amphetamine induced less dopamine efflux in mice lacking αCaMKII. Consistent with this observation, the acute locomotor responses to amphetamine were also significantly blunted in αCaMKII-deficient mice. In addition, while the rewarding properties of amphetamine were preserved in αCaMKII-deficient mice, their behavioral sensitization to amphetamine was markedly reduced. Our findings demonstrate that amphetamine requires the presence of αCaMKII to elicit a full-fledged effect on DAT in vivo: αCaMKII does not only support acute amphetamine-induced dopamine efflux but is also important in shaping the chronic response to amphetamine.
publisher Nature Publishing Group
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207348/
_version_ 1613148052096286720